<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04980339</url>
  </required_header>
  <id_info>
    <org_study_id>2021 ASO V1.0</org_study_id>
    <nct_id>NCT04980339</nct_id>
  </id_info>
  <brief_title>Multimodal Imaging Evaluation and Prognostic Analysis of Participants After Arterial Switch Operation</brief_title>
  <official_title>Multimodal Imaging Evaluation and Prognostic Analysis of Participants With Transposition of the Great Arteries After Arterial Switch Operation: a Multi-site Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xie Mingxing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Asia Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wuhan Union Hospital, China</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this study are to&#xD;
&#xD;
        1. Identify the early and midterm outcomes in terms of mortality and reoperation of the&#xD;
           arterial switch operation (ASO).&#xD;
&#xD;
        2. Identifying the influence of coronary artery anomalies on the in-hospital and&#xD;
           post-discharge prognosis after ASO.&#xD;
&#xD;
        3. Evaluate the predictors for neoaortic valve regurgitation after ASO.&#xD;
&#xD;
        4. Explore the risk factors for neopulmonary artery stenosis after ASO.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will enroll participants with transposition of the great arteries (TGA) and double&#xD;
      outlet right ventricle with subpulmonary ventricular septal defect (VSD) (Taussig-Bing&#xD;
      anomaly, TBA). The cardiac structure and function will be evaluated by multimodal imaging&#xD;
      including transthoracic echocardiographic examination, stress echocardiography, cardiac&#xD;
      computed tomography scan, cardiovascular magnetic resonance imaging.&#xD;
&#xD;
      And the study aimed to:&#xD;
&#xD;
        1. Identify the early and midterm outcomes in terms of mortality and reoperation of the&#xD;
           arterial switch operation (ASO) in participants with transposition of the great arteries&#xD;
           (TGA) and double outlet right ventricle with subpulmonary ventricular septal defect&#xD;
           (VSD) (Taussig-Bing anomaly, TBA).&#xD;
&#xD;
        2. Identifying subclinical coronary abnormalities and silent myocardial ischemia by&#xD;
           multimodel Imaging, further determine the influence of coronary artery anomalies on the&#xD;
           in-hospital and post-discharge prognosis in participants with TGA and TBA after ASO.&#xD;
&#xD;
        3. Evaluate the time course and predictors for neoaortic root dilatation and neoaortic&#xD;
           valve regurgitation in participants with TGA and TBA after ASO by multimodel Imaging.&#xD;
&#xD;
        4. Assess the structure of the right ventricular outflow tract and neopulmonary artery in&#xD;
           participants with TGA and TBA after ASO by multimodel Imaging, and explore the incidence&#xD;
           and risk factors for neopulmonary artery stenosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2031</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2031</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>Ten years</time_frame>
    <description>Number of participants with all cause mortality after ASO</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac caused mortality</measure>
    <time_frame>Ten years</time_frame>
    <description>Number of participants with cardiac caused mortality after ASO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause reoperation</measure>
    <time_frame>Ten years</time_frame>
    <description>Number of participants with all cause reoperation after ASO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right-ventricular outflow tract obstruction and pulmonary branch stenosis</measure>
    <time_frame>Ten years</time_frame>
    <description>Degree of more than moderate right-ventricular outflow tract obstruction in millimetre of mercury, degree of pulmonary branch stenosis in millimetre of mercury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neoaortic valve regurgitation</measure>
    <time_frame>Ten years</time_frame>
    <description>Vena contracta width of neoaortic valve regurgitation in milimetre, ratio of Jet width/LVOT width in percentage</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Arterial Switch Operation</condition>
  <arm_group>
    <arm_group_label>ASO group</arm_group_label>
    <description>All participants with TGA/TBA after ASO</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All participants diagnosed with TGA or TBA underwent ASO in the hospital with an eligible&#xD;
        cardiovascular surgery center.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        ·Participants with the diagnosis of TGA or TBA underwent ASO.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with various forms of TGA undergoing Réparation à l'Etage Ventriculaire&#xD;
             procedure&#xD;
&#xD;
          -  Patients with various forms of TGA undergoing Rastelli procedure&#xD;
&#xD;
          -  Patients with various forms of TGA undergoing Nikaidoh procedure&#xD;
&#xD;
          -  Patients with various forms of TGA undergoing Fontan operation&#xD;
&#xD;
          -  Patients with various forms of TGA undergoing atrial repair (Mustard or Senning)&#xD;
             operations&#xD;
&#xD;
          -  ASO is used as a corrective therapy for prior operations.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li Zhang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Ultrasound, Union Hospital, Wuhan, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li Zhang, PhD</last_name>
    <phone>18907131488</phone>
    <email>zli429@hust.edu.cn</email>
  </overall_contact>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 10, 2021</study_first_submitted>
  <study_first_submitted_qc>July 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Wuhan Union Hospital, China</investigator_affiliation>
    <investigator_full_name>Xie Mingxing</investigator_full_name>
    <investigator_title>Head of Department of Ultrasound, Union Hospital</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

